Paul is new CEO at EvaluatePharma

Share this article:

EvaluatePharma named Debbie Paul to the position of CEO Americas, EvaluatePharma USA, effective immediately.

In the new post, Paul is leading the data analysis and forecasting firm's North American operations and its strategic expansion into Canada and Latin America. Jonathan de Pass remains as chief executive of the UK-based parent company, EvaluatePhar­ma Ltd., which he founded.

Paul has been with the firm since 2004, most recently serving as SVP, North America, and has 25 years of healthcare and life science industry experience, ranging from being a critical-care nurse manager to directing market research for Sandoz.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?